Skip to main content Skip to section navigation Skip to footer
CohBar, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Programs & Pipelines
    • Overview
    • Our Approach
    • CB4211
    • CB5138 Analogs
    • Posters & White Papers
  • Patient Resources
    • Overview
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Partners
  • Careers
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jun 17, 2020 9:00am EDT

CohBar Founder Dr. Nir Barzilai’s New Book “AGE LATER” Reveals that Aging Can Be Seen as a Preventable Disease

Jun 02, 2020 9:00am EDT

CohBar to Hold 2020 Annual Shareholder Meeting and Investor Update June 16, 2020

May 27, 2020 9:00am EDT

CohBar’s CEO to Participate on the New Breakthroughs in Aging Biology Panel at the BIO 2020 Digital Conference

May 14, 2020 4:02pm EDT

CohBar Reports First Quarter 2020 Financial Results and Provides Business Update

May 13, 2020 9:00am EDT

CohBar’s Chief Operating Officer Jon Stern Plans to Step Down from Management Role

May 05, 2020 9:00am EDT

CohBar To Target COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with its Apelin Receptor Agonist Peptides

May 01, 2020 11:00am EDT

CohBar’s Abstract for the American Thoracic Society 2020 International Conference Published in the American Journal of Respiratory and Critical Care Medicine

Apr 30, 2020 9:00am EDT

CohBar to Announce 2020 First Quarter Financial Results and Provide Business Update on May 14, 2020

Apr 14, 2020 8:30am EDT

CohBar Announces Acceptance of Late Breaking Abstract on its Antifibrotic Peptides at The American Thoracic Society 2020 International Conference

Mar 30, 2020 8:45am EDT

CohBar Provides Update on CB4211 Phase 1b Study for NASH and Obesity

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Page 18
  • Next Pagearrow_forward
  • Email Alerts
  • Tear Sheet
  • Contacts
©2023 CohBar, Inc. All Rights Reserved.
Privacy Policy Sitemap Terms of Use